The Program is designed to support basic science and clinical research in the field of pulmonary arterial hypertension. Areas of research may include, but are not limited to:

• Basic science underlying PAH
• Genetics of PAH
• Pathophysiology of PAH
• Epidemiology of PAH
• Techniques for early diagnosis of PAH

The Program is designed to support new original research. Proposals with significant scientific overlap with funded research projects from a peer review agency or industry source will not be considered.

As proposals are reviewed by an independent Scientific Review Committee (no Commercial involvement in review and selection, i.e., Marketing, Sales, and Commercial Strategy), no preference is given to proposals related to products of Gilead Sciences, Inc. All proposals are reviewed based upon the criteria outlined on this website.